-

07:05:04 AM

LIVE Real Time HSDT Stock Market News

HSDT - Helius Medical Technologies Inc

04/15/21 8:35 AM

Nasdaq : HSDT

Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the Planet MicroCap Showcase, which is being held

RHEA-AI

neutral

04/07/21 4:30 PM

Nasdaq : HSDT

Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021

Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that first quarter of fiscal year 2021 financial results will be released after the market

RHEA-AI

neutral

03/29/21 6:30 AM

Nasdaq : HSDT

Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS(TM) Device

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the

RHEA-AI

neutral

03/17/21 4:05 PM

Nasdaq : HSDT

Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rd

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that management will participate in the Investor Summit Group's Q1 Virtual Summit, which is

RHEA-AI

neutral

03/17/21 7:05 AM

Nasdaq : HSDT

Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the appointment of Sherrie Perkins, effective March 15, 2021. "Ms. Perkins' career history

RHEA-AI

neutral

03/10/21 4:05 PM

Nasdaq : HSDT

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today reported financial results for the quarter and full year ended December 31, 2020. Fourth Quarter and

RHEA-AI

neutral

02/01/21 5:15 PM

Nasdaq : HSDT

Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today the closing of an underwritten public offering of units for gross proceeds of approximately

RHEA-AI

neutral

01/28/21 8:30 AM

Nasdaq : HSDT

Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, announced today announced the pricing of an underwritten public offering of units for gross proceeds of

RHEA-AI

neutral

01/20/21 7:05 AM

Nasdaq : HSDT

Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services' Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today provided comments in response to a press release issued by the Centers for Medicare & Medicaid

RHEA-AI

very positive

01/19/21 7:05 AM

Nasdaq : HSDT

Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards

Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it

RHEA-AI

neutral